Ariad Pharmaceuticals Inc fka ARIA

[BTH]

if jp Morgan
can advise on what is the best partnership or should they just go
alone

So you think that Ariad Management (PhDs etc.) are going to see a sell-side analyst and try and get advice from them (an analyst who covers 30 other biotech companies and not Ariad, specifically) on how to partner the drug considering what they already know from partnering ridaforolimus, etc.?

Liklihood of that happening: 0.00000000001%

The chances of them going to see their investment banker and asking them about raising money is much higher.